Primary Choriocarcinoma Fallopian Tube - A Rare Case Report
Keywords:
Choriocarcinoma, Fallopian TubeAbstract
Primary Choriocarcinoma of the fallopian tube is a very rare entity, its incidence being 0.8% of Gestational Trophoblastic Disease (GTD). We report a case of primary choriocarcinoma of the fallopian tube. The histologic diagnosis of Choriocarcinoma of the Left fallopian tube was made This case of gestational choriocarcinoma of the Fallopian tube was confirmed by p57 immunostaining. The patient was given 2 courses of chemotherapy (EMA-CO regimen). The interval between the two courses was 3 weeks.
References
Parijatham BO, Gupta M. Primary Fallopian tube adenocarcinoma, J Clin Diagn Res, 2012;6(4):723–724.
Ajithkumar TV, Minimole AL, John MM, Ashokkumar OS. Primary Fallopian tube carcinoma. Obstet Gynecol Surv, 2005;60(4):247–252.
Goldstein DP, Berkowitz RS. Gestational trophoblastic disease. In Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG (eds). Abeloff’s clinical oncology. 4th edition, Elsevier-Churchill Livingstone, Philadelphia, 2008; Ch. 94.
Vimala N, Kumar S, Dadhwal V. Primary choriocarcinoma of the Fallopian tube. Int J Gynaecol Obstet, 2002; 79(1):37– 38.
Cabrero AI, Stolnicu S, Kiyokawa T, Yamada K, Nikaido T, Santiago-Payán H. Carcinoma of the Fallopian tube results of a multi-institutional retrospective analysis of
patients with evaluation of staging and prognostic factors. Ann Diagn Pathol, 2013;17(2):159–164.
Lee SM, Kang HJ, Young SO, Hong JS, Kim JW. A successfully treated case of primary tubal choriocarcinoma coexistent with viable intrauterine pregnancy. Gynecol Oncol. 2005;97(2):671-673.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Recent Advances in Pathology and Laboratory Medicine ( ISSN: 2454-8642 )
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.
